Buprenorphine vs Upadacitinib

Buprenorphine vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Buprenorphine and Upadacitinib.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4; Upadacitinib — C17H19F3N6O.

Molecular Weight: Buprenorphine — 467.6430 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Buprenorphine — Small molecule; Upadacitinib — Small molecule.